These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
495 related items for PubMed ID: 15927970
1. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Frangogiannis NG, Ren G, Dewald O, Zymek P, Haudek S, Koerting A, Winkelmann K, Michael LH, Lawler J, Entman ML. Circulation; 2005 Jun 07; 111(22):2935-42. PubMed ID: 15927970 [Abstract] [Full Text] [Related]
3. The role of the thrombospondins in healing myocardial infarcts. Chatila K, Ren G, Xia Y, Huebener P, Bujak M, Frangogiannis NG. Cardiovasc Hematol Agents Med Chem; 2007 Jan 29; 5(1):21-7. PubMed ID: 17266545 [Abstract] [Full Text] [Related]
4. Extracellular matrix remodeling in canine and mouse myocardial infarcts. Dobaczewski M, Bujak M, Zymek P, Ren G, Entman ML, Frangogiannis NG. Cell Tissue Res; 2006 Jun 29; 324(3):475-88. PubMed ID: 16496177 [Abstract] [Full Text] [Related]
5. The role of platelet-derived growth factor signaling in healing myocardial infarcts. Zymek P, Bujak M, Chatila K, Cieslak A, Thakker G, Entman ML, Frangogiannis NG. J Am Coll Cardiol; 2006 Dec 05; 48(11):2315-23. PubMed ID: 17161265 [Abstract] [Full Text] [Related]
6. Thrombospondin-1 in the trabecular meshwork: localization in normal and glaucomatous eyes, and induction by TGF-beta1 and dexamethasone in vitro. Flügel-Koch C, Ohlmann A, Fuchshofer R, Welge-Lüssen U, Tamm ER. Exp Eye Res; 2004 Nov 05; 79(5):649-63. PubMed ID: 15500824 [Abstract] [Full Text] [Related]
7. Interleukin-10 is not a critical regulator of infarct healing and left ventricular remodeling. Zymek P, Nah DY, Bujak M, Ren G, Koerting A, Leucker T, Huebener P, Taffet G, Entman M, Frangogiannis NG. Cardiovasc Res; 2007 May 01; 74(2):313-22. PubMed ID: 17188669 [Abstract] [Full Text] [Related]
9. Decreased expression of thrombospondin-1 in failing hearts may favor ventricular remodeling. Batlle M, Pérez-Villa F, Lázaro A, García-Pras E, Vallejos I, Sionis A, Castel MA, Roig E. Transplant Proc; 2009 Jul 01; 41(6):2231-3. PubMed ID: 19715883 [Abstract] [Full Text] [Related]
10. Thrombospondin 1 and its mimetic peptide ABT-510 decrease angiogenesis and inflammation in a murine model of inflammatory bowel disease. Punekar S, Zak S, Kalter VG, Dobransky L, Punekar I, Lawler JW, Gutierrez LS. Pathobiology; 2008 Jul 01; 75(1):9-21. PubMed ID: 18334835 [Abstract] [Full Text] [Related]
11. Vascular mural cells in healing canine myocardial infarcts. Dobaczewski M, Akrivakis S, Nasser K, Michael LH, Entman ML, Frangogiannis NG. J Histochem Cytochem; 2004 Aug 01; 52(8):1019-29. PubMed ID: 15258177 [Abstract] [Full Text] [Related]
12. The role of thrombospondin-1 and transforming growth factor-beta after spinal cord injury in the rat. Wang X, Chen W, Liu W, Wu J, Shao Y, Zhang X. J Clin Neurosci; 2009 Jun 01; 16(6):818-21. PubMed ID: 19342245 [Abstract] [Full Text] [Related]
13. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo. Daniel C, Schaub K, Amann K, Lawler J, Hugo C. Diabetes; 2007 Dec 01; 56(12):2982-9. PubMed ID: 17878288 [Abstract] [Full Text] [Related]
14. Platelets, thrombospondin-1 and human dermal fibroblasts cooperate for stimulation of endothelial cell tubulogenesis through VEGF and PAI-1 regulation. Kellouche S, Mourah S, Bonnefoy A, Schoëvaert D, Podgorniak MP, Calvo F, Hoylaerts MF, Legrand C, Dosquet C. Exp Cell Res; 2007 Feb 01; 313(3):486-99. PubMed ID: 17126831 [Abstract] [Full Text] [Related]
15. Protection of erythropoietin on experimental spinal cord injury by reducing the expression of thrombospondin-1 and transforming growth factor-beta. Fang XQ, Fang M, Fan SW, Gu CL. Chin Med J (Engl); 2009 Jul 20; 122(14):1631-5. PubMed ID: 19719963 [Abstract] [Full Text] [Related]
16. Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction. Timmers L, van Keulen JK, Hoefer IE, Meijs MF, van Middelaar B, den Ouden K, van Echteld CJ, Pasterkamp G, de Kleijn DP. Circ Res; 2009 Mar 13; 104(5):699-706. PubMed ID: 19168865 [Abstract] [Full Text] [Related]
17. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy. Göser S, Ottl R, Brodner A, Dengler TJ, Torzewski J, Egashira K, Rose NR, Katus HA, Kaya Z. Circulation; 2005 Nov 29; 112(22):3400-7. PubMed ID: 16316965 [Abstract] [Full Text] [Related]
18. Dynamic changes in the expression of growth factor receptors in the myocardium microvascular endothelium after murine myocardial infarction. Wang XH, Zhang GP, Jin HM, Chen SF. Chin Med J (Engl); 2007 Mar 20; 120(6):485-90. PubMed ID: 17439742 [Abstract] [Full Text] [Related]
19. Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. Vandervelde S, van Amerongen MJ, Tio RA, Petersen AH, van Luyn MJ, Harmsen MC. Cardiovasc Pathol; 2006 Mar 20; 15(2):83-90. PubMed ID: 16533696 [Abstract] [Full Text] [Related]
20. Essential role of Smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Bujak M, Ren G, Kweon HJ, Dobaczewski M, Reddy A, Taffet G, Wang XF, Frangogiannis NG. Circulation; 2007 Nov 06; 116(19):2127-38. PubMed ID: 17967775 [Abstract] [Full Text] [Related] Page: [Next] [New Search]